Bimoclomol protects against vascular consequences of experimental subarachnoid hemorrhage in rats

Brain Research Bulletin

Volumn 45, Issue 2, 1998, Pages 163-166

  Erdö, Franciska ^a   Erdö, Sándor L ^a  

^a CNS of Biorex R and D Co   (Hungary)

Author keywords

Bimoclomol; Blood brain barrier; Brain edema; GYKI 52466; Subarachnoid hemorrhage

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; ALPHA TOCOPHEROL; ARACHIDONIC ACID; BIMOCLOMOL; BRLP 42; HEAT SHOCK PROTEIN; NEUROPROTECTIVE AGENT; TIRILAZAD; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN MICROCIRCULATION; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFICACY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE;

ANIMALS; ANTI-ANXIETY AGENTS; ARACHIDONIC ACID; BENZODIAZEPINES; BRAIN EDEMA; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR CIRCULATION; EXCITATORY AMINO ACID ANTAGONISTS; IMIDES; MALE; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; SUBARACHNOID HEMORRHAGE;

EID: 0031964929     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(97)00333-X     Document Type: Article

References (38)

1. Bíró K., Jednákovits A., Jaszlits L., Hegedüs E., Kukorelli T. Improvement of streptozotocin-diabetic neuropathy by BRLP-42. Diabetologia. 37:(Suppl. 1):1994;A73.
2. Bíró K., Jednákovits A., Kukorelli T., Hegedüs E., Korányi L. Bimoclomol (BRLP-42) ameliorates peripheral neuropathy in streptozotocin-induced diabetic rats. Brain Res. Bull. 44:1997;259-263.
3. Bíró, K.; Tóth, S.; Jaszlits, L.; Jednákovits, A. Hegedüs, E.; Kürthy, M.; Korányi, L. The Therapeutic effect of BRLP-42 on diabetic alterations of the ERG in rats. XXXIII. Symposium of International Society for Clinical Electrophysiology of Vision, Athens, Greece, June 16-20, 1995.
4. Chan P. H., Fishman R. A., Caronna J., Schmidley J. W., Prioleau G., Lee J. Induction of brain edema following intracerebral injection of arachidonic acid. Ann. Neurol. 13:1983;625-632.
5. Hall E. D., Mark A. T. Inhibition of arachidonic acid-induced vasogenic brain edema by the non-glucocorticoid 21-aminosteroid U74006F. Brain Res. 451:1988;350-352.
6. Hegedüs E., Bíró K., Jaszlits L., Jednákovits A., Kürthy M., Bácsy E. Protective effect of BRLP-42 on experimental retinopathy. Diabetologia. 37:(Suppl. 1):1994;A37.
7. Jaszlits, L.; Bíró, K.; Jednákovits, A.; Kürthy, M.; Hegedüs, E. Effects of BRLP-42 on STZ-induced cardiac autonomic neuropathy (CAN) in rats. XV. World Congress of the Int. Soc. for Heart Research, "Cardiovascular Alterations in Diabetes Mellitus," Budapest, Hungary, May 17-20, 1995.
8. Jaszlits L., Kékesi V., Juhász-Nagy A. Prevention of neuropathic circulatory dysfunction by BRLP-42 in diabetic dogs. Diabetologia. 39:(Suppl. 1):1996;A249.
9. Jaszlits, L.; Jednákovits, A.; Koltai, M.; Bíró, K.; Hegedüs, E.; Udvardy, É.; Vereczkey, L.; Literáti-Nagy, P.; Pogátsa, G. Antiischemic efficacy of BRLP-42. J. Mol. Cell. Cardiol. 25(Suppl. 1):XIP20; 1993.
10. Kinouchi H., Sharp F. R., Chan P. H., Koistinaho J., Sagar S. M., Yoshimoto T. Induction of c-fos, jun-B c-jun, and hsp70 mRNA in cortex, thalamus, basal ganglia and hippocampus following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 13:1994;105-115.
11. Lombardi G., Moroni F., Moroni F. Glutamate receptor antagonists protect against ischemia induced retinal damage. Eur. J. Pharmacol. 271:1994;489-495.
12. Lowenstein D. H., Chan P. H., Miles M. F. The stress protein response in cultured neurons Characterization and avidence for a protective role in excitotoxicity . Neuron. 7:1991;1053-1060.
13. Lowenstein D. H., Simon R. P., Sharp F. R. The pattern of 72kd heat shock protein-like immunoreactivity in the rat btain following flurothyl-induced status epilepticus. Brain Res. 531:1990;173-182.
14. Löscher W., Hönack D. Effect of the non-NMDA antagonist NBQX and the 2,3-benzodiazepine GYKI-52466 on different seizure types in mice Comparison with diazepam and interactions with flumazenil . Br. J. Pharmacol. 113:1994;1349-1357.
15. Marfaing-Jallat P., Portha B., Penicaud L. Altered conditioned taste aversion and glucose utilization in related brain nuclei of diabetic GK rats. Brain Res. Bull. 37:1995;639-643.
16. Marini A. M., Kozuka M., Lipsky R. H., Nowak T. S. 70-Kilodalton heat shock protein induction in cerebellar astrocytes and cerebellar granule cells in vitro Comparison with immunocytochemical localization after hyperthermia in vivo . J. Neurochem. 54:1990;1509-1516.
17. Matz P., Weinstein P., States B., Honkaniemi J., Sharp F. R. Subarachnoid injection of lysed blood induced the hsp70 stress gene and produced DNA fragmentation in focal areas of the rat brain. Stroke. 27:1996;504-512.
18. Nowak T. S., Bond U., Schleisinger M. J. Heat shock RNA levels in brain and other tissues after hyperthermia and transient ischemia. J. Neurochem. 54:1990;451-458.
19. Nowak T. S. ; Synthesis of a stress protein following transient ischemia in the gerbil. J. Neurochem. 45:1985;1635-1641.
20. Osipenko O., Mike A., Gyevai A., Vizi E. S. Evidence that GYKI-52466, a novel non-NMDA antagonist enhances the decay of kainate-induced current in cultured chicken cortical neurons. Dev. Brain Res. 77:1994;257-263.
21. Rordorf G., Koroshetz W. J., Bonventre J. V. Heat shock protects cultured neurons from glutamate toxicity. Neuron. 7:1991;1043-1051.
22. Rosivall, L.; Molnár, M.; Tóth, T.; Pittner, J.; Jaszlits, L. Mechanism and prevention of glomerular sclerosis in hypertensive diabetic rats. XXXII Congress of EDTA-European Nephrology Association, June 11-14, 1995, Athens, Greece.
23. Sango K., Horie H., Okamura A., Inoue S., Takenaka T. Diabetes impairs DRG neuronal attachment to extracellular matrix protein in vitro. Brain Res. Bull. 37:1995;533-537.
24. Sharp F. R., Lowenstein D., Simon R. P., Hisange K. Heat shock protein HSP-72 induction in cortical and striatal astrocytes and neurones following infarction. J. Cereb. Blood Flow Metab. 11:1991;621-627.
25. Shimosaka S., So Y. T., Simon R. P. Distribution of HSP72 induction and neuronal death following limbic seizures. Neurosci. Lett. 138:1992;202-206.
26. Simon R., Lowenstein D. Prior ischemic stress protects against experimental stroke. Neurosci. Lett. 163:1993;135-137.
27. Simon R., Cho J., Gwinn R., Lowenstein D. The temporal profile of 72kd heat shock protein expression following global ischemia. J. Neurosci. 11:1991;881-889.
28. Sloviter R. S., Lowenstein D. H. Heat shock expression in vulnerable cells of the rat hippocampus as an indicator of excitation induced neuronal stress. J. Neurosci. 12:1992;3004-3009.
29. Tarnawa I., Engberg I., Flatman J. A. GYKI-52466, an inhibitor of spinal reflexes is a potent quisqualate antagonist. Lubec G., Rosenthal G. A. Amino acids Chemistry, biology, and medicine . 1990;538-546 ESCOM Science Publisher B. V. Leiden.
30. Tarnawa I., Farkas S., Berzsenyi P., Pataki A., Andrási F. Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant GYKI-52466 . Eur. J. Pharmacol. 167:1989;193-199.
31. Tarnawa I., Farkas S., Berzsenyl P., Pátfalusi M., Andrási F. Reflex inhibitory action of a non-NMDA type excitatory amino acid antagonist, GYKI-52466. Acta Physiol. Hung. 75S:1990;277-278.
32. Travis M. A., Hall E. D. The effect of chronic two fold dietary vitamin E supplementation on subarachnoid hemorrhage-induced brain hypoperfusion. Brain Res. 418:1987;366-370.
33. Vass K., Berger M. L., Nowak T. S., Welch W. J., Lassman H. Induction of stress protein HSP70 in nerve cells after status epilepticus in the rat. Neurosci. Lett. 100:1989;259-264.
34. Vígh, L.; Literáti-Nagy, P.; Horváth, I.; Török, Zs.; Balogh, G.; Glatz, A.; et al. BRLP-42, a new generation of drugs acting as a chaperone inducer. Molecular Chaperones & The Heat Shock Response, Abstract: p. 348. Cold Spring Harbor Laboratory, May 1-5, 1996.
35. Vizi E. S., Mike A., Tarnawa I. 2,3-Benzodiazepines (GYKI-52466 and analogues) Negative allosteric modulators of AMPA receptors . CNS Drug Rev. 2:1996;91-126.
36. 2 radicals in arachidonate-induced blood-brain barrier permeability to proteins. Am. J. Physiol. 251:1986;H693-H699.
37. Zuccarello M., Douglas K. A. Protective effect of a 21-aminosteroid on the blood-brain barrier following subarachnoid hemorrhage in rats. Stroke. 20:1989;367-371.
38. 2+ in subarachnoid hemorrhage-induced spasm of the rabbit basilar artery. Stroke. 27:1996;1896-1902.